Court rules companies can't import Gilead medications from overseas in blow to AFP health programs
CNBC · C · trust 41/100
A U.S. appeals court has ruled in favor of Gilead Sciences against companies known as alternative funding programs that import medicines from overseas.
Read the original at CNBC →
Open in TruthVane →